Shanghai, China

Zhi-Dong Hu

This inventor holds 1 USPTO granted patent. Top assignees: Fudan University, Id Pharma Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhi-Dong Hu. Retrieved from https://idiyas.com/inventor/zhi-dong-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhi-Dong Hu: Innovator in Vaccine Development

Introduction

Zhi-Dong Hu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of vaccine development, particularly in the area of tuberculosis prevention. His innovative approach utilizes a recombinant Sendai virus vector to create a therapeutic and preventive vaccine.

Latest Patents

Zhi-Dong Hu holds 1 patent for his work titled "Anti-vaccine using Sendai virus as vector." This patent describes a recombinant Sendai virus vector vaccine that expresses immunodominant antigens, which can be utilized as a therapeutic and preventive vaccine against tuberculosis.

Career Highlights

Throughout his career, Zhi-Dong Hu has worked with notable institutions, including Fudan University and Id Pharma Co., Ltd. His research has focused on developing effective vaccine strategies to combat infectious diseases.

Collaborations

Zhi-Dong Hu has collaborated with esteemed colleagues such as Xiao-Yong Fan and Tsugumine Shu. These partnerships have contributed to the advancement of his research and the development of innovative vaccine solutions.

Conclusion

Zhi-Dong Hu's work in vaccine development showcases his commitment to addressing public health challenges. His innovative use of viral vectors in vaccine technology represents a significant advancement in the fight against tuberculosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…